Baden, D., Zukunft, S., Hernandez, G., Wolgast, N., Steinhauser, S., Pohlmann, A., Schliemann, C., Mikesch, J.-H., Steffen, B., Sauer, T., Hanoun, M., Schafer-Eckart, K., Krause, S. W., Hanel, M., Einsele, H., Jost, E., Brummendorf, T. H., Scholl, S., Hochhaus, A., Neubauer, A., Burchert, A., Kaufmann, M., Niemann, D., Schaich, M., Blau, W., Kiani, A., Gorner, M., Kaiser, U., Kullmer, J., Weber, T., Berdel, W. E., Ehninger, G., Muller-Tidow, C., Platzbecker, U., Serve, H., Bornhauser, M., Rollig, C., Baldus, C. D. and Fransecky, L. (2020) “Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2024.285225.